Metformin use and long-term risk of benign prostatic hyperplasia: a population-based cohort study.
Mette NørgaardBianka DarvalicsReimar Wernich ThomsenPublished in: BMJ open (2020)
Compared with sulfonylurea, metformin did not substantially reduce the incidence of BPH in men with diabetes.